Cargando…

Publisher Correction: ‘TRAIL-based gene delivery and therapeutic strategies’ and ‘Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy’

Detalles Bibliográficos
Autores principales:	Zhong, Hui-ha, Wang, Hui-yuan, Gao, Jian, Huang, Yong-zhuo, Gao, Ang, Hu, Xian-li, Saeed, Madiha, Chen, Bin-fan, Li, Ya-ping, Yu, Hai-jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115661/ https://www.ncbi.nlm.nih.gov/pubmed/32632210 http://dx.doi.org/10.1038/s41401-020-0444-0

Ejemplares similares

Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy
por: Gao, Ang, et al.
Publicado: (2019)

TRAIL-based gene delivery and therapeutic strategies
por: Zhong, Hui-hai, et al.
Publicado: (2019)

Recent advances in the liposomal nanovesicles based immunotherapy in the treatment of cancer: A review
por: Alhamhoom, Yahya, et al.
Publicado: (2023)

An overview of recently published medical papers in Brazilian scientific journals
por: Rocha e Silva, Mauricio, et al.
Publicado: (2011)

Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
por: Gu, Zili, et al.
Publicado: (2020)

Recent Developments in Liposome-Based Veterinary Therapeutics
por: Sadozai, Hassan, et al.
Publicado: (2013)

Recent Advances in Liposome-Based Molecular Robots
por: Shoji, Kan, et al.
Publicado: (2020)

Applications of Chondrocyte-Based Cartilage Engineering: An Overview
por: Phull, Abdul-Rehman, et al.
Publicado: (2016)

A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy
por: Satta, Alessandro, et al.
Publicado: (2019)

Recent Advances in Liposomal-Based Anti-Inflammatory Therapy
por: van Alem, Carla M. A., et al.
Publicado: (2021)

An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy
por: Vanneste, Ben G. L., et al.
Publicado: (2021)

Engineering Nanoparticles to Reprogram the Tumor Immune Microenvironment for Improved Cancer Immunotherapy
por: Saeed, Madiha, et al.
Publicado: (2019)

Recent Advances in Oral Peptide or Protein-Based Drug Liposomes
por: Cui, Jian, et al.
Publicado: (2022)

Recent Advance of Liposome Nanoparticles for Nucleic Acid Therapy
por: Gao, Yongguang, et al.
Publicado: (2023)

Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer
por: Chang, Rui, et al.
Publicado: (2023)

Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer
por: Guo, Liangran, et al.
Publicado: (2012)

Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
por: Qian, Chen, et al.
Publicado: (2020)

Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments
por: Brandi, Giovanni, et al.
Publicado: (2019)

Publishing Statistical Models Overview
por: Feickert, Matthew
Publicado: (2022)

GSH depletion liposome adjuvant for augmenting the photothermal immunotherapy of breast cancer
por: Zhou, Zhanwei, et al.
Publicado: (2020)

Overview of Recent Advances in Nano-Based Ocular Drug Delivery
por: Liu, Li-Ching, et al.
Publicado: (2023)

The landscape overview of CD47-based immunotherapy for hematological malignancies
por: Yang, Hua, et al.
Publicado: (2023)

Publisher Correction: The influence of liposomal quercetin on liver damage induced by microwave ablation
por: Duan, Xuhua, et al.
Publicado: (2017)

Privacy-Preserving Data Publishing: An Overview
por: Wong, Raymond Chi-Wing, et al.
Publicado: (2010)

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018)

TRAIL inhibits platelet-induced colorectal cancer cell invasion
por: Wu, Li-Sha, et al.
Publicado: (2019)

Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021)

Retinoblastoma: Recent trends A mini review based on published literature
por: Khetan, Vikas, et al.
Publicado: (2011)

Quality of reporting of systematic reviews published in “evidence-based” Chinese journals
por: Li, Jin-long, et al.
Publicado: (2014)

Micelle-in-Liposomes for Sustained Delivery of Anticancer Agents That Promote Potent TRAIL-Induced Cancer Cell Apoptosis
por: Zhang, Zhenjiang, et al.
Publicado: (2020)

Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo
por: Li, Qinghua, et al.
Publicado: (2018)

Immunotherapy of hepatocellular carcinoma: recent progress and new strategy
por: Li, Jiarui, et al.
Publicado: (2023)

Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
por: Pauli, Griffin, et al.
Publicado: (2021)

Tumor microenvironment-responsive DNA-based nanomedicine triggers innate sensing for enhanced immunotherapy
por: Li, Jinyang, et al.
Publicado: (2023)

Nanomedicine-based multimodal therapies: Recent progress and perspectives in colon cancer
por: He, Yu-Chu, et al.
Publicado: (2023)

Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges
por: Liu, Zhaoyuan, et al.
Publicado: (2021)

Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
por: Matsuo, Kazuhiko, et al.
Publicado: (2021)

Recent Advances in CAR-Based Solid Tumor Immunotherapy
por: Shin, Min Hwa, et al.
Publicado: (2023)

Recent advances in exosome-based immunotherapy applied to cancer
por: Xie, Jindong, et al.
Publicado: (2023)

Anti–phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy
por: Zheng, Chunxiong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3vuh1fidgg9tqvdqcmvej6nu1f